Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

How The DNA Catalog ExAC Will Improve Diagnoses And Patient Care

August 18, 2016 By Malcolm Ritter, AP Science Writer

A huge catalog of human DNA is helping researchers find tiny glitches that cause disease, in part by pointing out some false leads.

The database, with genetic codes from more than 60,000 people, is aimed at researching rare diseases that are generally caused by a single malfunctioning gene. Most of these diseases are so uncommon that the general public has never heard of them, but there are thousands of such conditions, and as a group they affect about one percent of births.

Better accuracy in identifying the genetic cause of a person’s disease provides a “clear and direct benefit to patients,” says Daniel MacArthur of the Broad Institute in Cambridge, Massachusetts and Massachusetts General Hospital in Boston.

He is senior author of an analysis published Wednesday in the journal Nature by researchers who compiled the database, which draws on DNA data from more than two dozen disease studies. It went online in 2014 and has since been consulted more than 5 million times, he says.

For rare diseases, doctors try to find the genetic cause by analyzing the patient’s DNA. But everybody carries tens of thousands of minute differences from the standard DNA code, and the goal is to find which one or two of them is making the person sick.

Researchers frequently do that through guilt by association. If a variation shows up in a patient but it is never seen or extremely rare in others, it may be fingered as the cause of disease.

The challenge is getting enough DNA from the general public. If the sampling is too small or not comprehensive enough for diverse populations, a variant may be wrongly blamed as the cause of the patient’s problems. A better sampling might show the variant actually appears in healthy people often enough that it’s clearly not making anybody sick.

False leads can harm patient care, including in some cases missing out on treatments, MacArthur says.

An example of such a “genetic misdiagnosis” was presented Wednesday in an unrelated study in the New England Journal of Medicine. It focused on an inherited disease called hypertrophic cardiomyopathy, which thickens heart muscle and can interfere with pumping blood.

Examining three years of records from a testing lab, it found that seven patients were told they carried one of two DNA variants that had been linked to the heart disease. Both variants were later reclassified as benign.

At least five of the patients were of African ancestry. If the original studies of those variants had included enough black Americans in their samples, they probably would not have reached the wrong conclusion, the Harvard researchers say.

They said the new DNA catalog, dubbed ExAC, is well-equipped to avoid such errors. It provides a far more comprehensive collection of DNA variations than has been available in the past. The roughly 10 million tiny variations listed are from people of European, African, South Asian, East Asian, and Latino ancestry.

In a separate study, released Wednesday by the journal Genetics in Medicine, British authors used ExAC data to cast doubt on recent reports that implicated some genes in hypertrophic cardiomyopathy and a second heart muscle disease.

The analysis in Nature provided another example of how ExAC can point out past mistakes. Researchers looked at 192 DNA variations that had been linked to diseases, but which ExAC showed were actually so common in the general population that those links appeared spurious.

The researchers find that under standard criteria, at least 163 should be reclassified as benign or probably benign. As of last December, 126 had been reclassified, the researchers report. That probably reflects the influence of the ExAC database, MacArthur says

But databases even bigger than ExAC will be needed to decisively link genetic variations to disease or rule them out, he said. “We have a long way to go,” he says.

Jay Shendure, a genetics expert at the University of Washington in Seattle who didn’t participate in the new work, says the ExAC catalog offers advantages over previous databases. There’s “little doubt” that it will accelerate and refine the search for disease causes and genetic aspects of patient care, he writes in a Nature commentary.

Related Articles Read More >

This is a Zimmer Biomet marketing image of its Rosa robotic surgery system.
Zimmer Biomet seeks a ZBEdge for its Rosa robotic surgery
A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe